Coverage, Access, and ACIP Recommendations: What Consumers Should Know about Respiratory Vaccines Heading into Fall
Recent changes to recommendations for respiratory vaccines have left patients and providers with pressing questions about vaccine access and coverage. Following its most recent meeting in September, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended COVID-19 vaccines for those 6 months and older based on “individual decision-making.” This change in recommendation illuminated the need for stakeholders to have clarity on the impact of ACIP recommendations on respiratory vaccine insurance coverage.
CVEEP hosted a timely discussion on this topic as experts in healthcare coverage, public health, and vaccine policy broke down the relationship between ACIP recommendations and coverage among different types of insurance plans, what to expect at your vaccination appointments this year, and how to advocate for yourself as a patient seeking fall vaccines.
Panelists included:
- Chris Regal, MS, Director of Clinical Innovation, AHIP
- Margot Savoy, MD, MPH, Chief Medical Officer, American Academy of Family Physicians (AAFP)
- Allison Hill, PharmD, RPh, Director of Professional Affairs, American Pharmacists Association (APhA)
- Moderator: Serese Marotta, Deputy CEO, Vaccinate Your Family